Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-26 07:08 am Sale | 2023-04-17 | 13D | Calithera Biosciences, Inc. CALA | TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% | -857,844 (Position Closed) | Filing History |
| 2023-02-14 11:48 am Purchase | 2022-12-31 | 13G | Calithera Biosciences, Inc. CALA | BIOTECHNOLOGY VALUE FUND L P | 488,367 9.990% | 488,367 (New Position) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Calithera Biosciences, Inc. CALA | Citadel Advisors LLC | 249,336 5.100% | 249,336 (New Position) | Filing History |
| 2023-02-09 4:02 pm Purchase | 2022-12-31 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO | 401,080 8.240% | 201,117 (+100.58%) | Filing History |
| 2023-02-09 4:01 pm Sale | 2023-01-31 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO | 199,963 4.110% | -206,317 (-50.78%) | Filing History |
| 2023-02-08 4:05 pm Sale | 2023-01-13 | 13G | Calithera Biosciences, Inc. CALA | INCYTE CORP INCY | 0 0.000% | -86,022 (Position Closed) | Filing History |
| 2022-12-08 11:49 am Purchase | 2022-11-30 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO | 406,280 8.350% | 406,280 (New Position) | Filing History |
| 2022-07-06 06:12 am Purchase | 2022-07-01 | 13D | Calithera Biosciences, Inc. CALA | TAKEDA PHARMACEUTICAL CO LTD | 857,844 15.000% | 116,970 (+15.79%) | Filing History |
| 2022-04-21 06:06 am Purchase | 2021-10-18 | 13D | Calithera Biosciences, Inc. CALA | TAKEDA PHARMACEUTICAL CO LTD | 740,874 13.200% | 740,874 (New Position) | Filing History |
| 2022-04-11 4:03 pm Purchase | 2022-03-30 | 13G | Calithera Biosciences, Inc. CALA | Citadel Advisors LLC | 251,754 5.400% | 70,226 (+38.69%) | Filing History |
| 2022-02-14 06:26 am Sale | 2021-12-31 | 13G | Calithera Biosciences, Inc. CALA | Citadel Advisors LLC | 181,527 4.800% | -2,680 (-1.45%) | Filing History |
| 2022-02-10 12:22 pm Purchase | 2021-12-31 | 13G | Calithera Biosciences, Inc. CALA | PRIMECAP MANAGEMENT CO | 536,650 14.320% | 23,975 (+4.68%) | Filing History |
| 2022-02-10 09:12 am Sale | 2021-12-31 | 13G | Calithera Biosciences, Inc. CALA | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -200,000 (Position Closed) | Filing History |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | Calithera Biosciences, Inc. CALA | The Vanguard Group | 143,080 3.820% | -40,655 (-22.13%) | Filing History |
| 2021-12-10 1:13 pm Sale | 2021-11-30 | 13G | Calithera Biosciences, Inc. CALA | FEDERATED HERMES INC. FHI | 71 0.000% | -372,059 (-99.98%) | Filing History |
| 2021-11-22 4:05 pm Purchase | 2021-11-10 | 13G | Calithera Biosciences, Inc. CALA | Citadel Advisors LLC | 184,207 4.900% | 184,207 (New Position) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Calithera Biosciences, Inc. CALA | BlackRock Inc. BLK | 139,805 3.800% | -143,615 (-50.67%) | Filing History |
| 2021-07-08 5:00 pm Purchase | 2021-07-06 | 13G | Calithera Biosciences, Inc. CALA | BIOTECHNOLOGY VALUE FUND L P | 372,617 10.100% | 154,555 (+70.88%) | Filing History |
| 2021-02-16 3:32 pm Sale | 2020-12-31 | 13G | Calithera Biosciences, Inc. CALA | Point72 Asset Management, L.P. | 86,718 2.500% | -75,284 (-46.47%) | Filing History |
| 2021-02-12 1:18 pm Purchase | 2020-12-31 | 13G | Calithera Biosciences, Inc. CALA | FEDERATED HERMES INC. FHI | 372,130 10.550% | 25,400 (+7.33%) | Filing History |